LONDON, UK, November 22, 2008
/24-7PressRelease/ -- The FDA have confirmed they will be providing an insight into Polymorphic Forms in Abbreviated New Drug Applications (ANDAs).
Andre Raw, Ph.D, Senior Regulatory Chemist at the Office of Generic Drugs, based at the Centre of Drug Evaluation and Research (CDER) will be delivering the information via a presentation at the 6th annual IQPC Polymorphism & Crystallisation conference which takes place 11-13th March 2009 in London.
Dr. Raw will address the scientific considerations of polymorphism to drug product safety, efficacy and quality; as well as those considerations of polymorphism applicable to drug product formulation and process design.
Delegates will be provided with an overview of regulatory considerations of polymorphism in ANDA's as well as looking in more detail at question based review and interlinking regulatory considerations of polymorphism to pharmaceutical Quality by Design in ANDAs.
Sarah Haynes, Event Director at Pharma IQ responded to the confirmation saying "This is a great opportunity for the FDA to answer the attendees' most important questions. Having an official onsite is a rarity at any European conference and I am sure that this will make for interesting and varied discussion. It will certainly help support the event's aim to allow participants to take home essential practical advice and guidance."
About IQPC
IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape. For any more information please contact enquire@iqpc.co.uk
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Toby Cobbledick:Other Press Release Headlines:- Just In Time For Flu and Cold Season, Dr. Rick Nappi, CEO of Healthy Ride Pharmaceuticals, Inc. Announces the Launch of His Latest All Natural Nutraceutical Formulation, Imunx
- FDA Warned by Prominent Public Health Official About the Dangers of Banning the E Cigarette
- Wealth Masters International Offers Mitchell Dillman of DillmanSolutions the Keys to a Life of Wealth, Health and Wisdom
- Dr. Rick Nappi, N.D., DIHom, FBIH, and CEO of Healthy Ride Pharmaceuticals, Inc. Launches His Latest All Natural Nutraceutical Formulation, Viscerax Gastrointestinal (GI) Support Complex
- Trent Consultants News 'Clean Plate Club' May Turn Children Into Overeaters
- "One Hour At A Time" to Interview
Dr. David Mee-Lee, on VoiceAmerica
- Driving While Impaired: It's More Than DUI
- Mr. Goodcents Subs and Pastas Awards Corporate Resource Group with 2009 Partner of the Year Award
- Top LA Lawyer Attends 8th PubCon in Las Vegas
- PHOTO: Revenue Lost by Catalog Sellers, Direct Sellers Over Undeliverables and Returns Recaptured by Fresh Financial Product, Developed by Tony Gracia, CFO, Power Media Group
